Axial Therapeutics
320
Volume
+163%
Growth
exploding
About the Topic
Clinical-stage biopharmaceutical company focused on developing gut-restricted, small molecule therapeutics for central nervous system (CNS) disorders. Axial Therapeutics leverages groundbreaking microbiome science to address various diseases and disorders, including autism, differentiating itself through its unique approach to targeting the gut-brain axis. The company's primary target demographic includes patients suffering from CNS disorders and related conditions.
Axial Therapeutics was discovered on November 11th 2021 and it currently has a search volume of 320 with a growth of +99X+.
Key Indicators
Growth
- Exploding
- Regular
- Peaked
Speed
- Exponential
- Constant
- Stationary
Seasonality
- High
- Medium
- Low
Volatility
- High
- Average
- Low
Members Only
Try Exploding Topics Pro
Get Free, Unlimited Access for 7 Days.
Categories
Save this topic and build your own trend dashboard.
Available with Exploding Topics Pro, try it now.
1.1M+ trends in our growing database.